GENE ONLINE|News &
Opinion
Blog

Uncategorized
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
320 World Oral Health Day – Lifting the “mask mandate”, maintaining good oral hygiene and flashing a healthy and confident smile.
2023-03-19
Illumina launches its first product enabling long- and short-read sequencing on one instrument
2023-03-14
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
2023-02-28
On Rare Disease Day 2023 RemeGen Highlights Its Social Responsibility and Rare Disease Advocacy
2023-02-27
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
2023-02-27
Illumina Reveals NovaSeq™ X Series at the Illumina Genomics Forum
2022-09-29
QOL Medical’s Sucraid Single-Use Containers Approved For Patients With Sucrase Deficiency
2022-09-07
Ginkgo Bioworks Buys Baktus’ Epidemic-Predicting Tools
2022-08-22
New Long-acting Formulation could be Key in Curing TB
2022-08-10
Novel Inhalable COVID-19 Therapeutic Targeting Viral Replication
2022-08-10
AACR 2022: Stand Up to Cancer, Standing up to Treatment
2022-04-21
After Winning Approval for Its Painkiller in Thailand, Taiwan’s Lumosa Aims for Korea Nod
2022-01-02
1 2
LATEST
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
Degrader-Antibody Conjugates (DACs): Targeted Degradation for Therapeutics
2024-02-19
EVENT
Scroll to Top